CMIC Holdings Co Ltd
TSE:2309
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Johnson & Johnson
NYSE:JNJ
|
US |
|
Berkshire Hathaway Inc
NYSE:BRK.A
|
US |
|
Bank of America Corp
NYSE:BAC
|
US |
|
Mastercard Inc
NYSE:MA
|
US |
|
UnitedHealth Group Inc
NYSE:UNH
|
US |
|
Exxon Mobil Corp
NYSE:XOM
|
US |
|
Pfizer Inc
NYSE:PFE
|
US |
|
Nike Inc
NYSE:NKE
|
US |
|
Visa Inc
NYSE:V
|
US |
|
Alibaba Group Holding Ltd
NYSE:BABA
|
CN |
|
JPMorgan Chase & Co
NYSE:JPM
|
US |
|
Coca-Cola Co
NYSE:KO
|
US |
|
Verizon Communications Inc
NYSE:VZ
|
US |
|
Chevron Corp
NYSE:CVX
|
US |
|
Walt Disney Co
NYSE:DIS
|
US |
|
PayPal Holdings Inc
NASDAQ:PYPL
|
US |
CMIC Holdings Co Ltd
Free Cash Flow
CMIC Holdings Co Ltd
Free Cash Flow Peer Comparison
Competitors Analysis
Latest Figures & CAGR of Competitors
| Company | Free Cash Flow | CAGR 3Y | CAGR 5Y | CAGR 10Y | ||
|---|---|---|---|---|---|---|
|
|
CMIC Holdings Co Ltd
TSE:2309
|
Free Cash Flow
¥446m
|
CAGR 3-Years
N/A
|
CAGR 5-Years
-23%
|
CAGR 10-Years
-12%
|
|
|
S
|
Shin Nippon Biomedical Laboratories Ltd
TSE:2395
|
Free Cash Flow
¥2B
|
CAGR 3-Years
-23%
|
CAGR 5-Years
8%
|
CAGR 10-Years
N/A
|
|
|
Medinet Co Ltd
TSE:2370
|
Free Cash Flow
-¥1.4B
|
CAGR 3-Years
-6%
|
CAGR 5-Years
-17%
|
CAGR 10-Years
5%
|
|
|
CellSource Co Ltd
TSE:4880
|
Free Cash Flow
¥283m
|
CAGR 3-Years
-28%
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
|
Immuno-Biological Laboratories Co Ltd
TSE:4570
|
Free Cash Flow
¥226.8m
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
|
D
|
DNA Chip Research Inc
TSE:2397
|
Free Cash Flow
¥25.7m
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
CMIC Holdings Co Ltd
Glance View
CMIC Holdings Co., Ltd. engages in the provision of support services for pharmaceutical development, manufacturing, and sales. The company is headquartered in Minato-Ku, Tokyo-To and currently employs 5,569 full-time employees. The company went IPO on 2004-06-18. The Contract Research Organization (CRO) segment offers monitoring, data management, pharmaceutical consulting and nonclinical services. The Contract Manufacturing Organization (CMO) segment is engaged in the entrusted manufacture of drugs for pharmaceutical companies. The Contract Sales Organization (CSO) segment is engaged in the operation and marketing support for medicinal products. The Health Care segment conducts site support institute (SMO) business, and provides health care information services. The Intellectual Property Development (IPD) segment develops and sells diagnostic products and orphan drugs.
See Also
What is CMIC Holdings Co Ltd's Free Cash Flow?
Free Cash Flow
446m
JPY
Based on the financial report for Dec 31, 2023, CMIC Holdings Co Ltd's Free Cash Flow amounts to 446m JPY.
What is CMIC Holdings Co Ltd's Free Cash Flow growth rate?
Free Cash Flow CAGR 10Y
-12%
Over the last year, the Free Cash Flow growth was -89%.
